Accelerating diabetic wound healing by ROS-scavenging lipid nanoparticle-mRNA formulation.
Siyu WangYuebao ZhangYichen ZhongYonger XueZhengwei LiuChang WangDiana D KangHaoyuan LiXucheng HouMeng TianDinglingge CaoLeiming WangKaiyuan GuoBinbin DengDavid W McCombMiriam MeradBrian D BrownYizhou DongPublished in: Proceedings of the National Academy of Sciences of the United States of America (2024)
Current treatment options for diabetic wounds face challenges due to low efficacy, as well as potential side effects and the necessity for repetitive treatments. To address these issues, we report a formulation utilizing trisulfide-derived lipid nanoparticle (TS LNP)-mRNA therapy to accelerate diabetic wound healing by repairing and reprogramming the microenvironment of the wounds. A library of reactive oxygen species (ROS)-responsive TS LNPs was designed and developed to encapsulate interleukin-4 (IL4) mRNA. TS2-IL4 LNP-mRNA effectively scavenges excess ROS at the wound site and induces the expression of IL4 in macrophages, promoting the polarization from the proinflammatory M1 to the anti-inflammatory M2 phenotype at the wound site. In a diabetic wound model of db/db mice, treatment with this formulation significantly accelerates wound healing by enhancing the formation of an intact epidermis, angiogenesis, and myofibroblasts. Overall, this TS LNP-mRNA platform not only provides a safe, effective, and convenient therapeutic strategy for diabetic wound healing but also holds great potential for clinical translation in both acute and chronic wound care.
Keyphrases
- wound healing
- reactive oxygen species
- binding protein
- drug delivery
- cell death
- dna damage
- anti inflammatory
- poor prognosis
- palliative care
- high frequency
- intensive care unit
- risk assessment
- adipose tissue
- human health
- bone marrow
- long non coding rna
- health insurance
- hepatitis b virus
- oxidative stress
- single cell
- combination therapy
- respiratory failure
- endothelial cells
- aortic dissection